Mazumdar Claire (CIK 2034671) reported 36 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-12). Recent activity: Sell BCAX (10,000 shares), Buy BCAX (10,000 shares), Buy BCAX (10,000 shares), Sell BCAX (9,972 shares), Sell BCAX (28 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 10,000 | $279,750 |
| 2026-08-12 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 10,000 | $37,898 |
| 2026-07-14 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 10,000 | $37,898 |
| 2026-07-14 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 9,972 | $283,367 |
| 2026-07-14 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 28 | $831 |
| 2026-05-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 15,000 | $56,847 |
| 2026-05-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 12,022 | $239,982 |
| 2026-05-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 2,978 | $60,597 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 15,000 | $354,146 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 7,454 | $28,249 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 7,080 | $38,612 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 15,000 | $56,847 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 8,226 | $36,498 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 6,499 | $24,631 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 6,499 | $122,441 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 6,905 | $26,170 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 1,596 | $6,049 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 1,596 | $30,244 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 6,905 | $129,676 |
| 2026-03-11 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 36,766 | $139,343 |
| 2026-03-11 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 36,766 | $704,804 |
| 2026-03-06 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 1,786 | $33,470 |
| 2026-03-06 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 2,631 | $9,971 |
| 2026-03-06 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Sell | 2,631 | $49,279 |
| 2026-03-06 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | Buy | 1,786 | $6,769 |
Source: SEC Form 4 filings · as of 2026-08-12